Extraintestinal manifestations of inflammatory bowel disease: Epidemiology, diagnosis, and management

Author： Larsen Signe   Bendtzen Klaus   Nielsen Ole Haagen  

Publisher： Informa Healthcare

ISSN： 0785-3890

Source： Annals of Medicine, Vol.42, Iss.2, 2010-02, pp. : 97-114

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: vedolizumab as a treatment and cause of extra‐intestinal manifestations of inflammatory bowel disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 535-536

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of vedolizumab therapy on extra‐intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV‐IBD cohort

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 485-493

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cytokines in inflammatory bowel disease

By Beck P. L.   Wallace J. L.  

Mediators of Inflammation, Vol. 6, Iss. 2, 1997-04 ,pp. : 95-103

Informa Healthcare

Access to resources Recommend Favorite

Inflammatory bowel disease in Asia

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 3, 2010-03 ,pp. : 436-438

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inflammatory Bowel Disease

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. S3, 2015-09 ,pp. : 117-148

John Wiley & Sons Inc

Access to resources Recommend Favorite